Influenza A viruses (IAVs) possess a great zoonotic potential as they are able to infect
different avian and mammalian animal hosts, from which they can be transmitted to humans …

Viral infections, in addition to damaging host cells, can compromise the host immune
system, leading to frequent relapse or long-term persistence. Viruses have the capacity to …

H7N9 influenza viruses were first isolated in 2013 and continue to cause human infections.
H7N9 infections represent an ongoing public health threat that has resulted in 1344 cases …

Lonicera japonica Thunb, rich in chlorogenic acid (CHA), is used for viral upper respiratory
tract infection treatment caused by influenza virus, parainfluenza virus, and respiratory …

The recent increase in zoonotic avian influenza A (H7N9) disease in China is a cause of
public health concern. Most of the A (H7N9) viruses previously reported have been of low …

Observational data suggest that the treatment of influenza infection with neuraminidase
inhibitors decreases progression to more severe illness, especially when treatment is started …

Without baseline human immunity to the emergent avian influenza A (H7N9) virus,
neuraminidase inhibitors are vital for controlling viral replication in severe infections. An …

In early 2013, human infections caused by a novel H7N9 avian influenza virus (AIV) were
first reported in China; these infections caused severe disease and death. The virus was …

Avian influenza viruses rarely infect humans, but the recently emerged avian H7N9
influenza viruses have caused sporadic infections in humans in China, resulting in 440 …

Influenza viruses cause infectious respiratory disease characterized by fever, myalgia, and
congestion, ranging in severity from mild to life-threating. Although enormous efforts have …